Cheaper versions of obesity medications like Ozempic and Wegovy may be available in Canada by January, potentially reducing costs from $400 to under $100. Several companies are developing generic versions, which could be approved quickly. This change could improve access for many Canadians struggling with obesity, especially those on public insurance plans.
Read more@
